State Street Corp Editas Medicine, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Editas Medicine, Inc. stock. As of the latest transaction made, State Street Corp holds 2,462,022 shares of EDIT stock, worth $6.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,462,022
Previous 4,590,913 46.37%
Holding current value
$6.01 Million
Previous $21.4 Million 60.84%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.39 - $5.96 $7.22 Million - $12.7 Million
-2,128,891 Reduced 46.37%
2,462,022 $8.4 Million
Q2 2024

Aug 14, 2024
SELL
$4.67 - $7.28 $19.5 Million - $30.4 Million
-4,169,238 Reduced 47.59%
4,590,913 $21.4 Million
Q1 2024

May 15, 2024
BUY
$7.03 - $11.07 $25.9 Million - $40.9 Million
3,690,608 Added 72.8%
8,760,151 $65 Million
Q4 2023

Feb 14, 2024
SELL
$6.25 - $11.11 $4.38 Million - $7.79 Million
-701,399 Reduced 12.15%
5,069,543 $51.4 Million
Q3 2023

Nov 14, 2023
SELL
$6.92 - $9.31 $6.03 Million - $8.11 Million
-870,737 Reduced 13.11%
5,770,942 $45 Million
Q2 2023

Aug 14, 2023
SELL
$6.36 - $11.47 $9.68 Million - $17.5 Million
-1,522,512 Reduced 18.65%
6,641,679 $54.7 Million
Q1 2023

May 15, 2023
SELL
$7.03 - $11.53 $7.44 Million - $12.2 Million
-1,058,045 Reduced 11.47%
8,164,191 $59.2 Million
Q4 2022

Feb 14, 2023
BUY
$8.32 - $13.21 $23.9 Million - $38 Million
2,873,455 Added 45.26%
9,222,236 $81.8 Million
Q3 2022

Nov 15, 2022
SELL
$12.16 - $19.42 $18.6 Million - $29.7 Million
-1,531,109 Reduced 19.43%
6,348,781 $77.7 Million
Q2 2022

Aug 15, 2022
BUY
$9.99 - $21.35 $24 Million - $51.2 Million
2,399,852 Added 43.79%
7,879,890 $93.2 Million
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $31.1 Million - $60.9 Million
2,205,431 Added 67.35%
5,480,038 $104 Million
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $29.6 Million - $45.3 Million
1,116,589 Added 51.74%
3,274,607 $86.9 Million
Q3 2021

Nov 15, 2021
SELL
$39.27 - $72.94 $14.8 Million - $27.4 Million
-376,144 Reduced 14.84%
2,158,018 $88.7 Million
Q2 2021

Aug 16, 2021
BUY
$31.29 - $56.64 $6.58 Million - $11.9 Million
210,444 Added 9.06%
2,534,162 $144 Million
Q1 2021

May 17, 2021
BUY
$39.71 - $90.58 $2.32 Million - $5.29 Million
58,386 Added 2.58%
2,323,718 $97.6 Million
Q4 2020

Feb 16, 2021
SELL
$27.07 - $84.35 $17.4 Million - $54.3 Million
-643,231 Reduced 22.12%
2,265,332 $159 Million
Q3 2020

Nov 10, 2020
SELL
$28.06 - $37.16 $4.86 Million - $6.43 Million
-173,136 Reduced 5.62%
2,908,563 $81.6 Million
Q2 2020

Aug 14, 2020
BUY
$18.5 - $34.34 $19.5 Million - $36.2 Million
1,053,970 Added 51.98%
3,081,699 $91.2 Million
Q1 2020

May 11, 2020
BUY
$14.88 - $32.78 $30.2 Million - $66.5 Million
2,027,729 New
2,027,729 $40.2 Million

Others Institutions Holding EDIT

# of Institutions
247
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $168M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email